Hoffman W F, Alberts A W, Cragoe E J, Deana A A, Evans B E, Gilfillan J L, Gould N P, Huff J W, Novello F C, Prugh J D
J Med Chem. 1986 Feb;29(2):159-69. doi: 10.1021/jm00152a001.
A series of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic (heptanoic) acids and their lactone derivatives have been prepared and tested for inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vitro. A systematic exploration of the structure-activity relationships in this series led to the synthesis of (+)-trans-(E)-6-[2-[2,4-dichloro-6-[(4-fluorophenyl) methoxyl]phenyl]ethyl]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-one (66(+)), which has one-half of the inhibitory activity of compactin.
已制备了一系列7 -(取代芳基)-3,5 -二羟基-6 -庚烯酸(庚酸)及其内酯衍生物,并对其进行了体外抑制3 -羟基-3 -甲基戊二酰辅酶A还原酶的测试。对该系列化合物构效关系的系统探索导致了(+)-反式-(E)-6 - [2 - [2,4 -二氯-6 - [(4 -氟苯基)甲氧基]苯基]乙基]-3,4,5,6 -四氢-4 -羟基-2H -吡喃-2 -酮(66(+))的合成,其抑制活性为美伐他汀的一半。